The first-ever comprehensive report providing a political reading of the current evaluation and classification, or “scheduling” of drugs according to their harms (The Global Commission on Drug Policy)
Bibliography: International Policy Issues
Developments in the European cannabis market
This paper provides an overview of established and emerging cannabis products in Europe. For each type of product, major issues in its production, distribution, use and effects on health are detailed. In doing so, the paper seeks to inform a discussion of the new challenges that may emerge in the monitoring of these products and the consequences of their use (EMCDDA)
The International Narcotics Control Board on cannabis: A critique of the report for 2018
As can be seen over the past 45 years or so, the potency of the Report has arguably shifted away from the public and more towards influencing opinion within the UN’s central policy-making body on the issue of drugs, the Commission on Narcotic Drugs (IDPC)
General Report of Activities 2018 – Key achievements and governance: a year in review
The General Report of Activities is an annual publication providing a detailed progress report of the EMCDDA’s activities over a 12-month period. It catalogues the Centre’s achievements in each area of its annual work programme (EMCDDA)
European Drug Report 2019: Trends and Developments
he Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses. Together with the online Statistical Bulletin and 30 Country Drug Reports, it makes up the 2019 European Drug Report package – Download (EMCDDA)
Drugs in syringes from six European cities: results from the ESCAPE project 2017
In this pilot study, chemical analysis of the contents of used syringes collected from exchange sites reveals the drugs and drug combinations injected in the six participating European cities (EMCDDA)
Addressing Problematic Opioid Use in OECD Countries
This report presents evidence on the magnitude of problematic opioid use across OECD countries
Global Drug Survey – main findings (PDF)
Using data from the GDS2019 sample we ranked 13 drugs in terms of the percentage of people who recently used that drug, reported seeking emergency medical treatment (EMT) in the last 12 months. Download full PDF
Contemporary Asian Drug Policy
Insights and Opportunities for Change (RAND)
Penalties for drug law offences in Europe at a glance
On this page you can examine and compare the penalties, or rehabilitative responses, for the core offences of drug use, possession for personal use, and supply-related offences, across countries in Europe (EMCDDA)
An analysis of post-mortem toxicology practices in drug-related death cases in Europe
The objective of this report is to provide an updated analysis of the post-mortem toxicology practices of drug-related deaths (DRD) in Europe and to discuss the effect of these practices on the monitoring of DRDs (EMCDDA)
Death penalty in 2018: Facts and figures
Amnesty International recorded at least 690 executions in 20 countries in 2018, a decrease of 31% compared to 2017 (at least 993). This figure represents the lowest number of executions that Amnesty International has recorded in the past decade
WHO recommends rescheduling of cannabis
On 24 January 2019, the Director General of the World Health Organization sent a letter to the Secretary General of the United Nations recommending, among other things, that cannabis and associated substances be rescheduled in the international drug control framework (EMCDDA)
Psychotropic Substances – Technical Report
On an annual basis the Psychotropics Control Section of the INCB Secretariat publishes a technical report that provides an overview of the world wide licit manufacture, export, import, stocks and consumption of substances controlled under the Convention on Psychotropic Substances of 1971 (INCB)
Programming document 2019-21
This is the first Programming Document fully grounded in the EMCDDA Strategy 2025 and it sets a milestone in the strategic and operational planning framework of the EMCDDA
International guidelines on human rights and drug policy (PDF)
Responding to the harms associated with drug use and the illicit drug trade is one of the greatest social policy challenges of our time. All aspects of this challenge have human rights implications ( (UNAIDS), (UNDP), (WHO)
Current NPS Threats
a new publication, presents highlights from the UNODC Toxicology Portal
What we have learned over the last ten years:
A summary of knowledge acquired and produced by the UN system on drug-related matters (UNODC)
Drug prevention: exploring a systems perspective
This report considers substance use prevention in Europe through the lens of a system, highlighting the wide range of factors that need to be addressed to successfully implement substance use prevention programmes and policies (EMCDDA)
Drug treatment systems in the Western Balkans: outcomes of a joint EMCDDA-UNODC survey of drug treatment facilities
This report presents a summary of the key findings from drug treatment facility surveys carried out in 2017 in Albania, Bosnia and Herzegovina, Serbia and the territory of Kosovo. The results provide insight into the characteristics and capacity of the treatment systems, as well as the availability and provision of treatment intervention (EMCDDA)
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 12
- Next Page »
